Search Within

Breast Medicine Service

Formats
  1. Journal Article (2206)
  2. Meeting Abstract (1680)
  3. Review (83)
  4. Book Section (69)
  5. Editorial (44)
  6. Conference Paper (28)
  7. Guidelines (27)
  8. Correspondence (16)
  9. Miscellaneous (12)
  10. Research Letter (11)
  11. Book Whole (5)
Groups
  1. Department of Medicine (4181)
  2. Solid Tumor Oncology Division (4181)
  3. Survivorship Research (2373)
  4. GSK Faculty (1516)
  5. Population Sciences Research Program (1369)
  6. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (1144)

More Groups

People
  1. Clifford Hudis (906)
  2. Larry Norton (762)
  3. Mark Robson (684)
  4. Neal Rosen (427)
  5. Andrew Seidman (319)
  6. Kenneth Offit (300)

More People

Years
  1. 2025 (130)
  2. 2024 (195)
  3. 2023 (168)
  4. 2022 (219)
  5. 2021 (236)
  6. 2020 (250)

More Years

Publications
  1. Journal of Clinical Oncology (828)
  2. Cancer Research (481)
  3. Breast Cancer Research and Treatment (170)
  4. Annals of Oncology (159)
  5. Clinical Cancer Research (132)
  6. Cancer (78)

More Publications

Publishers
  1. American Society of Clinical Oncology (880)
  2. American Association for Cancer Research (755)
  3. Springer (332)
  4. Elsevier Inc. (308)
  5. Oxford University Press (282)
  6. Nature Publishing Group (276)

More Publishers

Results (4181)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Randomized phase II trial of nanoparticle albumin-bound paclitaxel in three dosing schedules with bevacizumab as first-line therapy for HER2-negative metastatic breast cancer (MBC)
    Meeting Abstract

    Conlin, A. K.; Hudis, C. A.; Bach, A.; Moynahan, M.; Lake, D.; Forero-Torres, A.; Wright, G.; Hackney, M.; Clawson, A.; Seidman, A. D.
    Journal of Clinical Oncology (2009)

    Fulltext@MSK | Save
  • Evaluation of the correlation of baseline blood pressure (BP) and plasma renin activity (PRA) with bevacizumab (B)-mediated hypertension in patients with early-stage breast cancer
    Meeting Abstract

    Dickler, M. N.; McArthur, H. L.; Nulsen, B.; Patil, S.; Sealey, J.; Laragh, J.; Merali, C.; Steingart, R.; Hudis, C.; Rugo, H.
    Journal of Clinical Oncology (2009)

    Fulltext@MSK | Save
  • Phase IIb double-blind, randomized, placebo-controlled trials for the efficacy and safety of sorafenib in patients (pts) with metastatic or locally advanced breast cancer (BC): Review of the Trials to Investigate the Effects of Sorafenib in BC (TIES) program
    Meeting Abstract

    Baselga, J.; Gianni, L.; Gradishar, W. J.; Hudis, C.; Perez, E. A.; Piccart-Gebhart, M.; Schwartzberg, L. S.; Sledge, G.; Fleming, T. R.
    Journal of Clinical Oncology (2009)

    Fulltext@MSK | Save
  • Employment status among low-income Caucasian and Latina breast cancer survivors
    Meeting Abstract

    Blinder, V. S.; Patil, S.; Diamant, A.; Thind, A.; Maly, R.
    Journal of Clinical Oncology (2009)

    Fulltext@MSK | Save
  • The impact of obesity on adherence to the National Comprehensive Cancer Network (NCCN) guidelines recommending chemotherapy for patients with operable breast cancer
    Meeting Abstract

    Brewster, A. M.; Etzel, C.; Zhou, R.; Wong, Y.; Edge, S. B.; Blayney, D. W.; Wilson, J.; Hudis, C.; Weeks, J. C.; Theriault, R. L.
    Journal of Clinical Oncology (2009)

    Fulltext@MSK | Save
  • Phase II trial of the oral PARP inhibitor olaparib in BRCA-deficient advanced breast cancer
    Meeting Abstract

    Tutt, A.; Robson, M.; Garber, J. E.; Domchek, S.; Audeh, M. W.; Weitzel, J. N.; Friedlander, M.; Carmichael, J.
    Journal of Clinical Oncology (2009)

    Fulltext@MSK | Save
  • High dose cytarabine (HiDAC) and mitoxantrone (MITO) is an effective induction therapy for high-risk acute myeloid leukemia (AML)
    Meeting Abstract

    Larson, S.; Campbell, N.; Huo, D.; Artz, A.; Zhang, Y.; Gajria, D.; Green, M.; Rahimova, G.; Weiner, H.; Torres, M.; more...
    Blood (2009)

    Fulltext@MSK | Save
  • Histone deacetylases are required for androgen receptor function in hormone-sensitive and castrate-resistant prostate cancer
    Journal Article

    Welsbie, D. S.; Xu, J.; Chen, Y.; Borsu, L.; Scher, H. I.; Rosen, N.; Sawyers, C. L.
    Cancer Research (2009)

    Fulltext@MSK | Save
  • Dose-dense adjuvant doxorubicin and cyclophosphamide is not associated with frequent short-term changes in left ventricular ejection fraction
    Journal Article

    Morris, P. G.; Dickler, M.; Mcarthur, H. L.; Traina, T.; Sugarman, S.; Lin, N.; Moy, B.; Come, S.; Godfrey, L.; Nulsen, B.; more...
    Journal of Clinical Oncology (2009)

    Fulltext@MSK | Save
  • Genetic predictors of MEK dependence in V600E BRAF mutant melanoma
    Meeting Abstract

    Xing, F.; Pratilas, C.; Persaud, Y.; Janakiraman, M.; Houghton, A.; Rosen, N.; Solit, D.
    Cancer Research (2009)

    Fulltext@MSK | Save